EP3254675
Tafin losun, skammtasamsetningar fyrir inntöku um munn sem innihalda formlaust CDDO-ME
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.2.2010EP published:
15.5.2019EP application number:
17181174.8
EP translation filed:
25.6.2019Grant published:
15.7.2019EPO information:
European Patent Register
Max expiry date:
11.2.2030Expiry date:
11.2.2026Next due date:
28.2.2026
Title:
DELAYED RELEASE, ORAL DOSAGE COMPOSITIONS THAT CONTAIN AMORPHOUS CDDO-ME
Timeline
Today
12.2.2010EP application
15.5.2019EP Publication
25.6.2019Translation submitted
15.7.2019Registration published
11.2.2026Expires
Owner
Name:
Reata Pharmaceuticals Holdings, LLCAddress:
5320 Legacy Drive, Plano, TX 75024, US
Inventor
Name:
ZHANG, JiangAddress:
Coppell, Texas, US
Name:
MEYER, Colin J.Address:
Frisco, Texas, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
152608 PDate:
13.2.2009Country:
US
Classification
Categories:
A61K 9/16, A61K 9/48, A61K 31/70
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 18.12.2019
Expires: 11.2.2021
Payer: Árnason Faktor
Number: 12
Paid: 16.12.2020
Expires: 11.2.2022
Payer: Árnason Faktor ehf.
Number: 13
Paid: 22.12.2021
Expires: 11.2.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 25.1.2023
Expires: 11.2.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 22.12.2023
Expires: 11.2.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 29.1.2025
Expires: 11.2.2026
Payer: Árnason Faktor ehf.